# A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

> clinical trial · VERIFIED · 2026-08-31

Status: RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Breast Cancer

- Company: Hoffmann-La Roche
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07054190

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.